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Stenotrophomonas maltophilia is a Gram-nega-
tive pathogen with emerging nosocomial incidence 
[1]. It has been associated with several clinical syn-
dromes, primarily in relation to the opportunistic in-
fection of immunocompromised patients. Although 
not an inherently virulent pathogen, its ability to 
colonise respiratory-tract epithelial cells and med-
ical-device surfaces makes it a ready coloniser of 
hospital settings. 
Antibiotic treatment of S. maltophilia is greatly 
hampered by extensive drug resistance [2]. Besides 
PRUH VSHFL¿F UHVLVWDQFHPHFKDQLVPV LWV FDSDFLW\
WR IRUPELR¿OPV FRQIHUV WKHEDFWHULXPDGGLWLRQDO
protection in front of the immune system, antibiotics 
and disinfectants [3]. 
The genomes of two different strains have been 
recently sequenced and compared [4] but no expres-
sion-pattern studies have been performed yet. In this 
communication, we present a comparative proteome 
analysis of four strains with different infective ca-
pacities, ATCC 13637 and the new clinical isolates 
M30, UV74 and E77.
0DWHULDOV	0HWKRGV
Bacterial strains and growth
Three new S. maltophilia strains were isolated. 
M30 from a patient with decubitus ulcer. E77 from 
sputum and UV74 from patient with a vascular ul-
cer .ATCC 13637 and clinical isolated S. malto-
philia strains were cultured in LB media to reach 
exponential growth. Total protein extract: 20ml of 
culture were washed with PBS and resuspended in 
lysis solution (8M urea, 2M thiourea, 2.5% CHAPS, 
2% ASB-14, 40mM Tris-HCL pH 8.8, 0.5% IPG). 
Then, samples were disrupted by sonication and 
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centrifuged. DIGE labeling: Samples were labeled 
as follows: Clinical strains with Cy3 (green), ATCC 
13637 strain with Cy5 (red) and the internal stan-
dard with Cy2 (Blue). 50 µg of each sample were 
mixed and the resulting 150 µg were loaded onto 
the IPG strips. 2-D Gel Electrophoresis: The IPG 
strips were 24cm long and the pH range was from 3 
to 10 lineal and 4 to 7. The sample was loaded with 
the cup-loading system. The second dimension was 
performed in 12.5% polyacrylamide gels. Gels were 
performed in triplicate for statistical analysis. Image 
analysis: Images were acquired immediately using 
a Typhoon scanner (GE Healthcare) and the image 
analysis was carried out with Samespots software 
(Nonlinear dynamics). In-Gel Tryptic Digestion: 
After image analysis silver staining of the gels was 
performed. The selected spots were excised from 
the acrylamide gel, and immediately destained and 
digested. MALDI-MS Analysis:ȝORIVDPSOHZDV
PL[HGZLWKȝORI+&&$7KLVPL[WXUHZDVDQD-
O\]HGZLWKDQ8OWUDÀH[0$/',72)%UXNHU)RU
PMF analysis, the MASCOT search engine (Matrix 
Science) was used with the following parameters: 
one missed cleavage permission, 50 ppm measure-
PHQW WROHUDQFHDQGDW OHDVW¿YHPDWFKLQJSHSWLGH
masses. In the searches, methionine oxidation and 
cystein carbamidomethylation were taken into ac-
FRXQWDVYDULDEOHPRGL¿FDWLRQV
Conclusions
A differential expression analysis of the proteo-
mes of newly isolated clinical strains of S. malto-
philia and the laboratory strain ATCC 13637 has 
been performed (Figure 1). Eye-inspection of the gel 
images readily suggests the existence of substantial 
differences between the two proteomes under the ex-
SHULPHQWDOFRQGLWLRQV7KHLGHQWL¿FDWLRQRIGLIIHUHQ-
tially expressed proteins in these strains shall provide 
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the basis for the interpretation of their phenotypic 
differences at a biomolecular level, with a special 
focus on infection and resistance mechanisms.
Figure 1. DIGE of the M30 and the ATCC 13637 S. malto-
philia strains 
On average, around 1500 spot features were 
detected on each analytical gel. Statistical analysis 
of gels allowed the detection of about 300 spots with 
VLJQL¿FDQWFKDQJHVEHWZHHQWKHFOLQLFDOLVRODWHVDQG
$7&&VWUDLQV:HKDYHLGHQWL¿HGGLIIHUHQWLDOO\
expressed proteins. Interestingly, some of these pro-
teins (Spot nº 9, 16 and 21) are involved in the fatty 
acid metabolism. Moreover, a protein involved in 
the poliketide sugar unit biosynthesis has also been 
LGHQWL¿HG 6SRW Q 7KHXSUHJXODWLRQRI WKHVH
proteins in the some of the clinical strains suggests 
a different membrane lipopolysaccharide composi-
WLRQZKLFK LQ WXUQ FRXOG EH UHODWHGZLWK ELR¿OP
formation and pathogenesis. A number of proteases 
are upregulated in the clinical strains (Spot nº 2, 14, 
22 and 23) that could also be potentially relevant to 
LQIHFWLRQ2WKHULGHQWL¿HGSURWHLQVDUHLQYROYHGLQ
protein synthesis (Spot nº 3, 4, 5, 13 and 17) and in 
amino acid metabolism (spot nº 12, 15 and 20). 
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